Treatment in a pediatric setting (HR = 0.53; 95% CI, 0.37-0.76), as well as treatment at NCI- or Children’s Oncology Group-designated centers (HR = 0.8; 95% CI, 0.66-0.96), appeared associated with significantly longer OS. In addition, treatment in a … Read more

Read More